127 related articles for article (PubMed ID: 35262187)
1. Yield of baseline imaging for distant metastases in high-risk primary melanoma.
Yan MK; Adler NR; Pan Y; Chamberlain A; Kelly J; Yap K; Voskoboynik M; Haydon A; Shackleton M; Mar VJ
J Surg Oncol; 2022 Jun; 125(8):1312-1317. PubMed ID: 35262187
[TBL] [Abstract][Full Text] [Related]
2. The role of surveillance imaging for resected high-risk melanoma.
Yan MK; Adler NR; Wolfe R; Pan Y; Chamberlain A; Kelly J; Yap K; Voskoboynik M; Haydon A; Shackleton M; Mar VJ
Asia Pac J Clin Oncol; 2023 Aug; 19(4):566-573. PubMed ID: 36540019
[TBL] [Abstract][Full Text] [Related]
3. Baseline staging in cutaneous malignant melanoma.
Hafner J; Schmid MH; Kempf W; Burg G; Künzi W; Meuli-Simmen C; Neff P; Meyer V; Mihic D; Garzoli E; Jungius KP; Seifert B; Dummer R; Steinert H
Br J Dermatol; 2004 Apr; 150(4):677-86. PubMed ID: 15099363
[TBL] [Abstract][Full Text] [Related]
4. Stage-Specific Risk of Recurrence and Death From Melanoma in Denmark, 2008-2021: A National Observational Cohort Study of 25 720 Patients With Stage IA to IV Melanoma.
Helvind NM; Brinch-Møller Weitemeyer M; Chakera AH; Hendel HW; Ellebæk E; Svane IM; Kjærskov MW; Bojesen S; Skyum H; Petersen SK; Bastholt L; Johansen C; Bidstrup PE; Hölmich LR
JAMA Dermatol; 2023 Nov; 159(11):1213-1222. PubMed ID: 37650576
[TBL] [Abstract][Full Text] [Related]
5. Staging of cutaneous melanoma.
Mohr P; Eggermont AM; Hauschild A; Buzaid A
Ann Oncol; 2009 Aug; 20 Suppl 6(Suppl 6):vi14-21. PubMed ID: 19617293
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic features correlated with paradoxical outcomes in stage IIC versus IIIA melanoma patients.
Tan SY; Najita J; Li X; Strazzulla LC; Dunbar H; Lee MY; Seery VJ; Buchbinder EI; Tawa NE; McDermott DF; Lee SJ; Atkins MB; Kim CC
Melanoma Res; 2019 Feb; 29(1):70-76. PubMed ID: 30169431
[TBL] [Abstract][Full Text] [Related]
7. Impact of American Joint Committee on Cancer 8th edition classification on staging and survival of patients with melanoma.
Kanaki T; Stang A; Gutzmer R; Zimmer L; Chorti E; Sucker A; Ugurel S; Hadaschik E; Gräger NS; Satzger I; Schadendorf D; Livingstone E
Eur J Cancer; 2019 Sep; 119():18-29. PubMed ID: 31401470
[TBL] [Abstract][Full Text] [Related]
8. Sentinel lymph node excision and PET-CT in the initial stage of malignant melanoma: a retrospective analysis of 61 patients with malignant melanoma in American Joint Committee on Cancer stages I and II.
Klode J; Dissemond J; Grabbe S; Hillen U; Poeppel T; Boeing C
Dermatol Surg; 2010 Apr; 36(4):439-45. PubMed ID: 20187901
[TBL] [Abstract][Full Text] [Related]
9. External validation of the American Joint Committee on Cancer 8th edition melanoma staging system: who needs adjuvant treatment?
Madu MF; Franke V; Van de Wiel BA; Klop WMC; Jóźwiak K; van Houdt WJ; Wouters MWJM; van Akkooi ACJ
Melanoma Res; 2020 Apr; 30(2):185-192. PubMed ID: 31651715
[TBL] [Abstract][Full Text] [Related]
10. Staging of regional nodes in AJCC stage I and II melanoma: 18FDG PET imaging versus sentinel node detection.
Belhocine T; Pierard G; De Labrassinne M; Lahaye T; Rigo P
Oncologist; 2002; 7(4):271-8. PubMed ID: 12185291
[TBL] [Abstract][Full Text] [Related]
11. Initial staging of malignant melanoma by positron emission tomography and sentinel node biopsy.
Libberecht K; Husada G; Peeters T; Michiels P; Gys T; Molderez C
Acta Chir Belg; 2005; 105(6):621-5. PubMed ID: 16438072
[TBL] [Abstract][Full Text] [Related]
12. Preoperative 18F-FDG-PET/CT imaging and sentinel node biopsy in the detection of regional lymph node metastases in malignant melanoma.
Singh B; Ezziddin S; Palmedo H; Reinhardt M; Strunk H; Tüting T; Biersack HJ; Ahmadzadehfar H
Melanoma Res; 2008 Oct; 18(5):346-52. PubMed ID: 18781133
[TBL] [Abstract][Full Text] [Related]
13. Melanoma-specific survival in patients with positive sentinel lymph nodes: Relevance of sentinel tumor burden.
Satzger I; Leiter U; Gräger N; Keim U; Garbe C; Gutzmer R
Eur J Cancer; 2019 Dec; 123():83-91. PubMed ID: 31677550
[TBL] [Abstract][Full Text] [Related]
14. Fluorodeoxyglucose positron emission tomography fails to detect distant metastases at initial staging of melanoma patients with metastatic involvement of sentinel lymph node.
Wagner T; Meyer N; Zerdoud S; Julian A; Chevreau C; Payoux P; Courbon F
Br J Dermatol; 2011 Jun; 164(6):1235-40. PubMed ID: 21332457
[TBL] [Abstract][Full Text] [Related]
15. Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma.
Wagner JD; Schauwecker D; Davidson D; Logan T; Coleman JJ; Hutchins G; Love C; Wenck S; Daggy J
Cancer; 2005 Aug; 104(3):570-9. PubMed ID: 15977211
[TBL] [Abstract][Full Text] [Related]
16. Prognostic and predictive value of AJCC-8 staging in the phase III EORTC1325/KEYNOTE-054 trial of pembrolizumab vs placebo in resected high-risk stage III melanoma.
Eggermont AMM; Blank CU; Mandala M; Long GV; Atkinson VG; Dalle S; Haydon A; Lichinitser M; Khattak A; Carlino MS; Sandhu S; Larkin J; Puig S; Ascierto PA; Rutkowski P; Schadendorf D; Koornstra R; Hernandez-Aya L; Di Giacomo AM; van den Eertwegh AJ; Grob JJ; Gutzmer R; Jamal R; Lorigan PC; Lupinacci R; Krepler C; Ibrahim N; Kicinski M; Marreaud S; van Akkooi AC; Suciu S; Robert C
Eur J Cancer; 2019 Jul; 116():148-157. PubMed ID: 31200321
[TBL] [Abstract][Full Text] [Related]
17. Risk and tropism of central nervous system (CNS) metastases in patients with stage II and III cutaneous melanoma.
Johannet P; Simons M; Qian Y; Azmy N; Mehnert JM; Weber JS; Zhong J; Osman I
Cancer; 2022 Oct; 128(20):3620-3629. PubMed ID: 36006879
[TBL] [Abstract][Full Text] [Related]
18. Management of adjuvant settings for Stage III melanoma patients in France prior to checkpoint inhibitors: epidemiological data from the RIC-Mel database.
Dalle S; Varey E; Nguyen JM; Dupuy A; Montaudie H; Lesage C; Mortier L; Leccia MT; Skowron F; Celerier P; Meyer N; Dutriaux C; Dalac-Rat S; Khammari A; Lebbe C; Dréno B
Eur J Dermatol; 2020 Aug; 30(4):389-396. PubMed ID: 32815816
[TBL] [Abstract][Full Text] [Related]
19. The value of lymph node ultrasound and whole body
Stahlie EHA; van der Hiel B; Bruining A; van de Wiel B; Schrage YM; Wouters MWJM; van Houdt WJ; van Akkooi ACJ
Eur J Surg Oncol; 2021 May; 47(5):1157-1162. PubMed ID: 33353826
[TBL] [Abstract][Full Text] [Related]
20. The Impact of Surveillance Imaging Frequency on the Detection of Distant Disease for Patients with Resected Stage III Melanoma.
Dieng M; Lord SJ; Turner RM; Nieweg OE; Menzies AM; Saw RPM; Einstein AJ; Emmett L; Thompson JF; Lo SN; Morton RL
Ann Surg Oncol; 2022 May; 29(5):2871-2881. PubMed ID: 35142966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
